NewsBenzingaLadenburg Thalmann Maintains Buy on NovoCure, Raises Price Target to $31 Ladenburg Thalmann Maintains Buy on NovoCure, Raises Price Target to $31 Benzinga 2026.11.10 22:05 (GMT+0) Open on Benzinga Other news MAS Plans SG Digital Ledger and 'Know Your Agent' Protocol Aon plc Stock: Analyst Estimates & Ratings What Are Wall Street Analysts' Target Price for American Water Works Stock? BIT: BBIT Secures FINMA Approval and Is Set to Launch, Currently Europe's Only Spot Bitcoin ETF LyondellBasell Stock Outlook: Is Wall Street Bullish or Bearish? Thermo Fisher Scientific Stock: Is Wall Street Bullish or Bearish?